Introducing our Speakers for #BCT2026
The Annual Scientific Meeting brings together Breast Cancer Trials (BCT) members, breast cancer researchers, and those involved in the conduct of clinical trials, to learn more about recent advances in breast cancer research worldwide, and the developments in BCT-conducted clinical trials.
Jana de Boniface
International Guest Speaker
Jana de Boniface
International Guest Speaker
Jana de Boniface is a general surgeon trained in Berlin, Germany, and Stockholm, Sweden.
Her clinical dedication lies in breast surgery and specifically in oncoplastic and reconstructive breast surgery, which she practices as a consultant at Capio Saint Göran’s Hospital in Stockholm, Sweden.
She is a passionate teacher with annual oncoplastic courses attracting an international faculty. As a clinical professor at Karolinska Institutet, she is well known for her large international SENOMAC trial in axillary surgery de-escalation and conducts both register-based and prospective clinical research aiming to individualise breast and axillary surgery in breast cancer to minimise its potentially negative impact on patients' quality of life without compromising survival outcomes.
Recently, she also dove into the area of exercise oncology, where she runs the largest internationally randomised trial on exercise as an addition to primary systemic therapy.
In recognition of her patient-centred and implementation-focused work, she received both the Annual Award by the patients’ national breast cancer association of Sweden and the Jubilee Award by the Swedish Medical Association in 2024.
Sara Hurvitz
International Guest Speaker
Sara Hurvitz
International Guest Speaker
Dr Sara Hurvitz is a medical oncologist and clinical research leader who is senior vice president of the Clinical Research Division at Fred Hutch and head of the Division of Hematology and Oncology at the University of Washington Department of Medicine.
A graduate of the Keck School of Medicine at the University of Southern California, Hurvitz is an international expert in breast oncology and a leader in clinical and laboratory-based oncology research, with extensive experience leading clinical trials in all phases.
Dr Hurvitz works to boost the national reputation of the solid tumor clinical research program and oversees the continued growth of clinical research programs in stem cell transplantation and cell therapy, hematologic cancers and nonmalignant hematology.
Dr Hurvitz has contributed extensively to the growth of clinical research programs since joining the University of California, Los Angeles as a resident in 1999. She is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, American Association for Cancer Research and the European Society of Medical Oncology.